Derivative exercise or conversion — not an open-market buy.
Loading…
Planned for Sep 14, 2026 · Notice filed Sep 14, 2026
A top manager at Moderna told the SEC they plan to sell $5.81M of Moderna shares around Sep 14, 2026. The shares came from their pay, which is the usual reason to sell. That is a tiny part of all Moderna shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
None found in footnotes
Only flagged when a footnote says so; never inferred
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$5.81M of Moderna
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.